Article
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Oncogene - 26 Aug 1999
Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C
Abstract excerpt
Chronic infection by HBV is the leading cause of hepatocellular carcinoma in man. Several lines of evidence suggest that the viral transactivator HBx plays a critical role in the molecular pathogenesis of HBV-related HCC. To study the actual impact of HBx and the mechanism of its action, we have recently cloned and characterized a set of X-sequences from HCC in patients with chronic infection by HBV. In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
